Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

Item
http://www.wikidata.org/entity/Q42723108
Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation.Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method.Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinib.Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia.A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer.Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin.A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects.Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.Bile acid is important for gastrointestinal absorption of nilotinib.
P2860

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

Item
http://www.wikidata.org/entity/Q42723108
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@en
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@nl
type
label
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@en
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@nl
prefLabel
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@en
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Influence of H2-receptor antag ...... in Japanese leukemia patients.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921